CAM
PFE icon

Chesapeake Asset Management’s Pfizer PFE Stock Holding History

Chesapeake Asset Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2
Closed -$3 – 432
2023
Q3 		$3 Buy
+2
New +$71 ﹤0.01% 441

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Chesapeake Asset Management's PFE Position: Q2 2026 in Review

Chesapeake Asset Management increased its Pfizer (PFE) stake by 0.91% in Q2 2026, buying an estimated $942 and bringing the position to 4,008 shares worth $96.5K. The position accounts for 0.07% of the portfolio, ranked #135.

Chesapeake Asset Management first reported a position in PFE in Q2 2013 and has held it in 41 quarters since. The position peaked at $1.04M in Q2 2016. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Chesapeake Asset Management held 4,008 shares of Pfizer worth $96.5K as of Q2 2026.
  • Chesapeake Asset Management bought 36 Pfizer shares in Q2 2026, an estimated $942.
  • Pfizer made up 0.07% of Chesapeake Asset Management's portfolio in Q2 2026, its #135 holding.
  • Chesapeake Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 41 quarters since.
  • Chesapeake Asset Management's Pfizer position peaked at $1.04M in Q2 2016.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Chesapeake Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.